These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 1230027

  • 41. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M, Guillaumet G, Coudert G, Pujol MD.
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [Abstract] [Full Text] [Related]

  • 42. Prolonged effects of chronic guanethidine treatment on the sympathetic innervation of the genitalia of male rats.
    Gannon BJ, Iwayama T, Burnstock G, Gerkens J, Mashford ML.
    Med J Aust; 1971 Jul 24; 2(4):207-8. PubMed ID: 5093864
    [No Abstract] [Full Text] [Related]

  • 43. Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons.
    Shore PA, Giachetti A.
    Biochem Pharmacol; 1966 Jul 24; 15(7):899-903. PubMed ID: 5338640
    [No Abstract] [Full Text] [Related]

  • 44. Action of a guanethidine analogue on adrenergic neurons and its relation to sodium.
    Misu Y, Matsuda T, Fujie K.
    Jpn J Pharmacol; 1980 Feb 24; 30(1):125-8. PubMed ID: 7401406
    [No Abstract] [Full Text] [Related]

  • 45. [Radiation shifts in the cerebral enzyme activity of rats following adrenoblockader administration].
    Kukulianskaia MF, Khripchenko IP, Novodvorskaia ZV, Fidrik IP.
    Radiobiologiia; 1976 Feb 24; 16(6):820-3. PubMed ID: 1027023
    [No Abstract] [Full Text] [Related]

  • 46. Interaction in vivo between chronically administered guanethidine and imipramine.
    Evans BK, Honey M, Burnstock G.
    Gen Pharmacol; 1979 Feb 24; 10(2):79-82. PubMed ID: 437484
    [No Abstract] [Full Text] [Related]

  • 47. Influence of two different beta-adrenergic blocking agents on the increase in fibrinolytic activity and factor VIII activity during submaximum and maximum exercise.
    Korsan-Bengtsen K, Conradson TB.
    Scand J Haematol; 1974 Feb 24; 13(5):377-84. PubMed ID: 4616332
    [No Abstract] [Full Text] [Related]

  • 48. The influence of beta-adrenoceptor antagonists on accommodation of the lens.
    Nyberg G.
    Clin Exp Pharmacol Physiol; 1976 Feb 24; 3(5):493-5. PubMed ID: 10118
    [Abstract] [Full Text] [Related]

  • 49. Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.
    Offerhaus L, van Zwieten PA.
    Cardiovasc Res; 1974 Jul 24; 8(4):488-95. PubMed ID: 4426059
    [No Abstract] [Full Text] [Related]

  • 50. Guanethidine after twenty years: a pharmacologist's perspective.
    Maxwell RA.
    Br J Clin Pharmacol; 1982 Jan 24; 13(1):35-44. PubMed ID: 6121572
    [No Abstract] [Full Text] [Related]

  • 51. Metabolic interaction of ethanol and alprenolol in isolated liver cells.
    Grundin R.
    Acta Pharmacol Toxicol (Copenh); 1975 Sep 24; 37(3):185-200. PubMed ID: 1242604
    [No Abstract] [Full Text] [Related]

  • 52. Axon retraction following guanethidine treatment: studies of sympathetic neurons in tissue culture.
    Heath JW, Hill CE, Burnstock G.
    J Neurocytol; 1974 Jun 24; 3(2):263-76. PubMed ID: 4600679
    [No Abstract] [Full Text] [Related]

  • 53. Degeneration of adrenergic neurons following guanethidine treatment: an ultrastructural study.
    Heath JW, Evans BK, Gannon BJ, Burnstock G, James VB.
    Virchows Arch B Cell Pathol; 1972 Jun 24; 11(2):182-97. PubMed ID: 4628152
    [No Abstract] [Full Text] [Related]

  • 54. Stimulation of presynaptic beta-adrenoceptors enhances [3H]-noradrenaline release druing nerve stimulation in the perfused cat spleen.
    Celuch SM, Dubocovich ML, Lander SZ.
    Br J Pharmacol; 1978 May 24; 63(1):97-109. PubMed ID: 206310
    [Abstract] [Full Text] [Related]

  • 55. The adrenergic neuron blocking activity of propranolol and alprenolol.
    Del Río J, López De Ceballos M.
    Arch Farmacol Toxicol; 1975 Aug 24; 1(2):125-36. PubMed ID: 1230027
    [No Abstract] [Full Text] [Related]

  • 56. Further studies on the adrenergic neuron blocking activity of some -adrenoceptor antagonists and guanethidine.
    Mylecharane EJ, Raper C.
    J Pharm Pharmacol; 1973 Mar 24; 25(3):213-20. PubMed ID: 4146321
    [No Abstract] [Full Text] [Related]

  • 57. Studies on the interactions of propranolol with adrenergic neurons.
    Saelens DA, Daniell HB, Webb JG.
    J Pharmacol Exp Ther; 1977 Sep 24; 202(3):635-45. PubMed ID: 894526
    [No Abstract] [Full Text] [Related]

  • 58. Adrenergic neurone blocking activity of some new guanidine derivatives.
    Kadzielawa K, Gumulka W.
    Arch Int Pharmacodyn Ther; 1967 Dec 24; 170(2):287-96. PubMed ID: 4294770
    [No Abstract] [Full Text] [Related]

  • 59. The importance of catecholamine uptake inhibition in the reversal of guanethidine blockade of adrenergic neurons.
    Lee CH, Strosberg AM, Warren LA.
    Res Commun Chem Pathol Pharmacol; 1980 Oct 24; 30(1):3-14. PubMed ID: 7433767
    [Abstract] [Full Text] [Related]

  • 60. The adrenergic neuron blocking activity of propranolol and alprenolol.
    Del Río J, López De Ceballos M.
    Arch Farmacol Toxicol; 1975 Aug 24; 1(2):125-36. PubMed ID: 1230027
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.